• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体铁释放导致依托泊苷和顺铂诱导的小细胞肺癌细胞干性。

Lysosome Fe release is responsible for etoposide- and cisplatin-induced stemness of small cell lung cancer cells.

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Department of Geriatrics, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

出版信息

Environ Toxicol. 2021 Aug;36(8):1654-1663. doi: 10.1002/tox.23161. Epub 2021 May 10.

DOI:10.1002/tox.23161
PMID:33969609
Abstract

Iron metabolism has been shown to hand over cancer stem cell, which is regarded as the root of tumor progression, recurrence and chemoresistance. This study aims to explore whether iron metabolism is involved in etoposide- and cisplatin-induced stemness in small cell lung cancer (SCLC) cells. Here, analysis on tumor-sphere formation and stemness marker expression is performed to determine whether etoposide and cisplatin can induce SCLC cell stemness. Online dataset analysis is constructed to determine the correlation between iron transportation and the survival of lung cancer patients. Chromatin immunoprecipitation combined with rescuing experiments are carried out to reveal the underlying mechanisms. Additionally, the non-lethal doses of etoposide and cisplatin can induce SCLC cell stemness in a concentration-dependent manner and reduce the lysosome iron concentration dependent on Ferritin expression, which is positively regulated by HIF-1α/β. Moreover, HIF-1α/β can directly bind to Ferritin promoter region. This HIF/Ferritin axis is responsible for etoposide- and cisplatin-induced iron reduction in lysosomes and stemness of SCLC cells. This work demonstrates that iron in lysosomes is essential for etoposide and cisplatin-induced stemness of SCLC cells, which is regulated by the HIF/Ferritin axis.

摘要

铁代谢被发现与癌症干细胞有关,癌症干细胞被认为是肿瘤进展、复发和化疗耐药的根源。本研究旨在探讨铁代谢是否参与依托泊苷和顺铂诱导的小细胞肺癌(SCLC)细胞干性。在此,通过肿瘤球形成和干性标志物表达分析来确定依托泊苷和顺铂是否能诱导 SCLC 细胞干性。构建在线数据集分析来确定铁转运与肺癌患者生存的相关性。通过染色质免疫沉淀结合挽救实验来揭示潜在的机制。此外,非致死剂量的依托泊苷和顺铂可以浓度依赖性地诱导 SCLC 细胞干性,并降低依赖于转铁蛋白表达的溶酶体铁浓度,转铁蛋白表达受 HIF-1α/β正向调节。此外,HIF-1α/β可以直接结合转铁蛋白启动子区域。这个 HIF/转铁蛋白轴负责依托泊苷和顺铂诱导的溶酶体中铁减少以及 SCLC 细胞的干性。这项工作表明,溶酶体中的铁对于依托泊苷和顺铂诱导的 SCLC 细胞干性是必不可少的,这是由 HIF/转铁蛋白轴调节的。

相似文献

1
Lysosome Fe release is responsible for etoposide- and cisplatin-induced stemness of small cell lung cancer cells.溶酶体铁释放导致依托泊苷和顺铂诱导的小细胞肺癌细胞干性。
Environ Toxicol. 2021 Aug;36(8):1654-1663. doi: 10.1002/tox.23161. Epub 2021 May 10.
2
Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.缺氧诱导因子-1α 和修复交叉互补基因 1 在接受一线铂类化疗的小细胞肺癌患者中的表达:一项回顾性研究。
J Thorac Oncol. 2012 Mar;7(3):528-34. doi: 10.1097/JTO.0b013e3182417830.
3
Hypoxia-induced Tie1 drives stemness and cisplatin resistance in non-small cell lung carcinoma cells.缺氧诱导的Tie1促进非小细胞肺癌细胞的干性和顺铂耐药性。
Cancer Cell Int. 2021 Jan 18;21(1):57. doi: 10.1186/s12935-020-01729-3.
4
Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy.临床前证据表明丙戊酸对小细胞肺癌对一线化疗反应的有益影响。
Eur J Cancer. 2010 Jun;46(9):1724-34. doi: 10.1016/j.ejca.2010.03.021. Epub 2010 May 5.
5
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial.一项多中心、随机、3期试验,比较顺铂+依托泊苷固定剂量与毒性调整剂量在广泛期小细胞肺癌(SCLC)患者中的疗效:小细胞肺癌毒性调整剂量(STAD-1)试验。
Lung Cancer. 2017 Jun;108:15-21. doi: 10.1016/j.lungcan.2017.02.016. Epub 2017 Feb 27.
6
Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience.顺铂、依托泊苷和贝伐单抗方案序贯口服依托泊苷和贝伐单抗维持治疗广泛期小细胞肺癌患者:单机构经验
Clin Lung Cancer. 2015 Nov;16(6):e229-34. doi: 10.1016/j.cllc.2015.05.005. Epub 2015 May 18.
7
Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients.顺铂联合依托泊苷治疗广泛期小细胞肺癌患者的数学优化
Br J Cancer. 2017 Jan;116(3):344-348. doi: 10.1038/bjc.2016.439. Epub 2017 Jan 12.
8
Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.顺铂-依托泊苷与卡铂-依托泊苷治疗小细胞肺癌患者的结局。
Am J Clin Oncol. 2015 Feb;38(1):51-4. doi: 10.1097/COC.0b013e31828aab2a.
9
[Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation 
with Concurrent Twice-daily Radiotherapy for Patients 
with Limited-stage Small Cell Lung Cancer].依托泊苷和顺铂化疗剂量递增联合每日两次同步放疗治疗局限期小细胞肺癌的I期研究
Zhongguo Fei Ai Za Zhi. 2017 Jan 20;20(1):55-60. doi: 10.3779/j.issn.1009-3419.2017.01.08.
10
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer.罗米司亭联合顺铂/依托泊苷或卡铂/依托泊苷作为广泛期小细胞肺癌一线治疗的 II 期研究。
J Thorac Oncol. 2019 Apr;14(4):701-711. doi: 10.1016/j.jtho.2019.01.010. Epub 2019 Jan 21.

引用本文的文献

1
Predictors of febrile neutropenia in small cell lung cancer patients receiving concurrent chemoradiotherapy with etoposide and cisplatin: a focus on nutritional status, inflammation, and performance status.接受依托泊苷和顺铂同步放化疗的小细胞肺癌患者发热性中性粒细胞减少的预测因素:聚焦营养状况、炎症和体能状态
Am J Cancer Res. 2025 Mar 15;15(3):1020-1035. doi: 10.62347/JRMG1142. eCollection 2025.
2
Identification and validation of a ferroptosis-related prognostic risk-scoring model and key genes in small cell lung cancer.小细胞肺癌中铁死亡相关预后风险评分模型及关键基因的鉴定与验证
Transl Lung Cancer Res. 2022 Jul;11(7):1380-1393. doi: 10.21037/tlcr-22-408.
3
Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis.
吩嗪衍生物通过触发铁死亡来减弱乳腺癌细胞的干性。
Cell Mol Life Sci. 2022 Jun 11;79(7):360. doi: 10.1007/s00018-022-04384-1.